Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Lurker Nancy Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4 Lurker Nancy (Executive Vice Chair) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 33,334 restricted stock units @ $0
Granted 66,666 options to buy @ $9.11, valued at $607.3k
05/15/2023 4 Lurker Nancy (CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Gifted 21,250 options to buy @ $36.3, valued at $771.4k
Gifted 21,250 options to buy @ $36.3, valued at $771.4k
Gifted 65,868 options to buy @ $26.5, valued at $1.7M
Gifted 65,868 options to buy @ $26.5, valued at $1.7M
Gifted 36,000 options to buy @ $20.4, valued at $734.4k
Gifted 36,000 options to buy @ $20.4, valued at $734.4k
Gifted 8,000 options to buy @ $17.7, valued at $141.6k
Gifted 8,000 options to buy @ $17.7, valued at $141.6k
Gifted 120,206 options to buy @ $13.13, valued at $1.6M
Gifted 120,206 options to buy @ $13.13, valued at $1.6M
Gifted 59,220 options to buy @ $12.9, valued at $763.9k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Lurker Nancy (CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 450,800 options to buy @ $3.26, valued at $1.5M
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 13,717 restricted stock units @ $0
02/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2021 4 Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $20.148, valued at $201.5k
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $4.04, valued at $80.8k
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2021 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2020 4 Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 14,000 options to buy @ $5.3, valued at $74.2k
06/16/2020 4 Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 45,000 restricted stock units @ $0
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/15/2019 4 Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 10,745 shares @ $2.105, valued at $22.6k
06/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2019 4 Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 45,000 restricted stock units @ $0
06/17/2019 4 Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 13,350 options to buy @ $4.38, valued at $58.5k
04/01/2019 4 Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Bought 28,500 shares @ $1.763, valued at $50.2k
10/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2018 4 Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 26,700 options to buy @ $15, valued at $400.5k
07/24/2018 3 Lurker Nancy (Director) has filed a Form 3 on Aquestive Therapeutics, Inc.
06/29/2018 4 Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 40,000 restricted stock units @ $0
06/18/2018 4 Lurker Nancy (President and CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 135,000 restricted stock units @ $0
Granted 540,000 options to buy @ $2.04, valued at $1.1M
03/21/2018 4 Lurker Nancy (President & CEO) has filed a Form 4 on pSivida Corp.
Txns: Granted 38,333 shares @ $0
12/19/2017 4 Lurker Nancy (President and CEO) has filed a Form 4 on pSivida Corp.
Txns: Granted 120,000 restricted stock units @ $0
Granted 240,000 options to buy @ $1.77, valued at $424.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy